BioPharma & Healthcare Related News

Kite Pharma’s Engineered T-Cell Therapies for Cancers Delivers Astonishing Results

Kite Pharma’s gene therapy trial has just delivered astonishing results: 41% of patients in response and 36% in complete response at month 6 after a single round of treatment. The news shook the bio and med industry last week, skyrocketing [...]

By | March 7th, 2017|BioPharma & Healthcare, News, Therapeutics|

46 Organizations Making Biology Easier to Engineer

Synthetic biology has been a joint effort since its conception. From academic researchers to legislators and venture capitalists, synbio as both a technology and innovation ecosystem has been forged by different hands and different perspectives. These are some of the [...]

Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases

PLYMOUTH MEETING, Pa., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that Dr. David B. Weiner, Inovio’s co-founder, presented positive clinical data on Inovio’s DNA-based vaccines against MERS (Middle East Respiratory Syndrome) (GLS-5300) and Zika (GLS-5700) [...]

By | February 26th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases, Therapeutics|

Isogenica Announces New Licence Agreement With Top-25 Global Pharmaceutical Company

Cambridge, UK | 21st February 2017. Isogenica Ltd, a leader in the design and construction of innovative and highly diverse synthetic antibody libraries, today announced a new licensing deal with a top-25 global pharmaceutical company which specialises in immunology, oncology and [...]

By | February 21st, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

3 Biotech Trends in 2017

Originally featured on SOSV As I start to look at the emerging trends of 2017 from the vantage of IndieBio, where we see hundreds of biotech startup applications and technologies per year, a few key themes are already emerging. Even as [...]

By | February 21st, 2017|BioPharma & Healthcare, News|

Cell Design Labs’ Scientific Founder Co-Authors Review Article Illustrating Power and Potential of Engineered Human Cells to Treat Cancer

EMERYVILLE, Calif., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Cell Design Labs, Inc. today announced that its scientific founder, Wendell Lim, Ph.D., co-authored a comprehensive review article on engineered cell therapies entitled, “The Principles of Engineering Immune Cells to Treat Cancer” [...]

By | February 14th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|